wegovy to tirzepatide conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Switching from Semaglutide to Tirzepatide:

It should not be stored

This enrichment suggests notable changes in energy metabolism, inflammatory signaling, and apoptotic processes following HFHFD exposure

consumption of fruit and vegetables is encouraged, whereas alcoholic beverages are better avoided 1

For example, a 2019 study found that eating a whole avocado with a meal elevated levels of GLP-1 and peptide YY (another hormone tied to fullness), while also lowering insulin levels

Clinical Trial Results: Weight Loss Compared Both tirzepatide and semaglutide have extensive clinical trial programs

The results were unambiguous: Source: Kato et al., Neuroendocrinology 1984